TY - JOUR
T1 - Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer
T2 - a cross-sectional study and the implications
AU - Dias-Godói, Isabella Piassi
AU - Tadeu Rocha Sarmento, Túlio
AU - Afonso Reis, Edna
AU - Peres Gargano, Ludmila
AU - Godman, Brian
AU - de Assis Acurcio, Francisco
AU - Alvares-Teodoro, Juliana
AU - Guerra Júnior, Augusto Afonso
AU - Mariano Ruas, Cristina
N1 - Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Introduction: The new coronavirus pandemic has appreciably impacted morbidity and mortality, as well as having an economic impact worldwide. New vaccines are a potential way forward to reduce transmission rates and subsequent infection. In Brazil, vaccines are being distributed via the public sector; however, in the future, they will be available in the private market. Information about consumers’ willingness to pay (WTP) for a hypothetical vaccine against SARS CoV-2 can help future price setting discussions. Methods: A cross-sectional study was conducted with consumers in the five regions of Brazil regarding the WTP for a hypothetical vaccine against SARS CoV-2 with a 50% efficacy. Results: A total of 1402 individuals over 18 years of age who declared not having COVID-19 at the time of the survey were interviewed. The acceptability for this hypothetical vaccine was 80.7%. In addition, the amount of WTP by Brazilian consumers for a hypothetical SARS CoV-2 vaccine was estimated at US$ 22.18(120.00 BRL). Conclusion: This study can contribute to decision-making to inform potential pricing for a hypothetical SARS CoV-2 vaccine.
AB - Introduction: The new coronavirus pandemic has appreciably impacted morbidity and mortality, as well as having an economic impact worldwide. New vaccines are a potential way forward to reduce transmission rates and subsequent infection. In Brazil, vaccines are being distributed via the public sector; however, in the future, they will be available in the private market. Information about consumers’ willingness to pay (WTP) for a hypothetical vaccine against SARS CoV-2 can help future price setting discussions. Methods: A cross-sectional study was conducted with consumers in the five regions of Brazil regarding the WTP for a hypothetical vaccine against SARS CoV-2 with a 50% efficacy. Results: A total of 1402 individuals over 18 years of age who declared not having COVID-19 at the time of the survey were interviewed. The acceptability for this hypothetical vaccine was 80.7%. In addition, the amount of WTP by Brazilian consumers for a hypothetical SARS CoV-2 vaccine was estimated at US$ 22.18(120.00 BRL). Conclusion: This study can contribute to decision-making to inform potential pricing for a hypothetical SARS CoV-2 vaccine.
KW - SARS cov-2
KW - brazil
KW - contingent valuation
KW - covid-19
KW - vaccine
KW - willingness to pay
UR - http://www.scopus.com/inward/record.url?scp=85107841900&partnerID=8YFLogxK
U2 - 10.1080/14737167.2021.1931128
DO - 10.1080/14737167.2021.1931128
M3 - Article
C2 - 33993823
AN - SCOPUS:85107841900
SN - 1473-7167
VL - 22
SP - 119
EP - 129
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 1
ER -
